Destiny Pharma (DEST) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Mar 2022 12:30 PM
RNS
Fundraising
08 Feb 2022 07:00 AM
RNS
Positive feedback from EMA on XF-73 Nasal gel Ph 3
01 Feb 2022 04:11 PM
RNS
Exercise of Options and Total Voting Rights
01 Feb 2022 07:00 AM
RNS
Positive data in XF-73 Dermal study with NIAID
31 Jan 2022 02:30 PM
RNS
Exercise of Options and Total Voting Rights
25 Jan 2022 07:00 AM
RNS
Grant of share options
24 Jan 2022 07:00 AM
RNS
Clinical and commercial opportunity of NTCD-M3
21 Jan 2022 07:15 AM
RNS
Destiny Pharma Lancet Report
17 Jan 2022 07:00 AM
RNS
Strategy/Company/Ops Update
21 Dec 2021 04:35 PM
RNS
Exercise of Options and Total Voting Rights
17 Dec 2021 09:46 AM
RNS
Grant of share options
15 Nov 2021 02:26 PM
RNS
Directorate Change
04 Nov 2021 07:00 AM
RNS
SAB Member Prof. Gerding is Keynote at C.diff Conf
18 Oct 2021 07:00 AM
RNS
Study gives strong support for potential of XF-73
27 Sep 2021 03:18 PM
RNS
Director/PDMR Shareholding
27 Sep 2021 07:00 AM
RNS
Expansion of clinical pipeline
09 Sep 2021 07:00 AM
RNS
Interim results for six months ended 30 June 2021
23 Aug 2021 07:00 AM
RNS
Notice of Interim Results
02 Aug 2021 07:00 AM
RNS
Secondary endpoint analysis from Phase 2b trial
09 Jul 2021 08:00 AM
RNS
XF-73 Phase 2b data to be presented at ECCMID
06 Jul 2021 07:00 AM
RNS
NTCD-M3 RD Agreement with US Dept Veterans Affairs
02 Jul 2021 08:00 AM
RNS
Scientific Advisor Gerding chairs C Diff symposium
29 Jun 2021 08:24 AM
RNS
DEST to present at Shares & AJ Bell Webinar 6/7/21
10 Jun 2021 05:00 PM
RNS
Director Dealing
10 Jun 2021 07:00 AM
RNS
XF-73 data abstract to be presented at 2021 ECCMID
07 Jun 2021 07:00 AM
RNS
Destiny Pharma welcomes G7's Communique on AMR
03 Jun 2021 12:03 PM
RNS
Result of AGM
02 Jun 2021 07:00 AM
RNS
Positive update on microbiome therapeutic NTCD-M3
25 May 2021 07:00 AM
RNS
Further information re AGM
19 May 2021 07:00 AM
RNS
Notice to Register for 2021 AGM
06 May 2021 10:00 AM
RNS
Conference Attendance for May 2021
04 May 2021 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
30 Apr 2021 07:00 AM
RNS
Director Dealing
23 Apr 2021 07:00 AM
RNS
Director Dealing
15 Apr 2021 08:00 AM
RNS
FY 2020 Investor Presentation
14 Apr 2021 07:00 AM
RNS
Final Results
29 Mar 2021 12:45 PM
RNS
Exercise of Options and Total Voting Rights
29 Mar 2021 12:00 PM
RNS
Destiny Pharma to Join Equity Development Webinar
29 Mar 2021 11:06 AM
RNS
Second Price Monitoring Extn
29 Mar 2021 11:00 AM
RNS
Price Monitoring Extension
29 Mar 2021 10:15 AM
RNS
Exercise of Options and Total Voting Rights
29 Mar 2021 09:06 AM
RNS
Second Price Monitoring Extn
29 Mar 2021 09:00 AM
RNS
Price Monitoring Extension
29 Mar 2021 07:00 AM
RNS
Destiny Pharma Reports Positive Phase 2b Results
16 Mar 2021 07:00 AM
RNS
Notice of Results
15 Mar 2021 07:00 AM
RNS
Destiny Pharma Announces Agreement with NIAID
10 Mar 2021 02:15 PM
RNS
Exercise of Options and Total Voting Rights
10 Mar 2021 07:00 AM
RNS
Destiny Pharma CSO Joins UKRI COVID-19 Taskforce
10 Feb 2021 02:05 PM
RNS
Second Price Monitoring Extn
10 Feb 2021 02:00 PM
RNS
Price Monitoring Extension

Destiny Pharma is a biotechnology company that develops and sells new medicines to prevent serious infections.

Destiny Pharma share price launched on AIM on August 18, 2017.

UK 100